Filter posts

Richard Pops: A Greater Patient Voice in Drug Development

In the October issue of MedNous, Alkermes’ CEO Richard Pops writes about the move toward …

4 Tips for Building a Successful Biotech: Richard Pops of Alkermes at #BIOCEO14

The 16th Annual BIO CEO & Investor Conference opened with a fireside chat between Richard …

2013 Novel Drug Approvals

The FDA approved 24 novel drugs last year by our count, in line with average …